Skip to main content

RSA to hold out for 600p offer from Zurich, reports say

Bag of money

Analysts estimate insurer's value at 550p per share.

The board of RSA are understood to be looking for a take-out price of 600p per share from potential bidder Zurich, according to reports by The Sunday Telegraph.

Following Zurich's announcement last week that it was considering a takeover of RSA advisers to RSA have been looking at the potential value of the company.

Value
Analysts told Insurance Age that the deal would be a "good fit" for the two insurers and estimated RSA's value to 550p per share.

RSA confirmed that it had not held any talks

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@insuranceage.co.uk or view our subscription options here: https://subscriptions.insuranceage.co.uk/subscribe

You are currently unable to copy this content. Please contact info@insuranceage.co.uk to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Insurance Age? View our subscription options

Register

Sign up and gain access to five complimentary news articles every month.

Already have an account? Sign in here

Show password
Hide password

Analysis: Are employee benefits the new diversification frontier for GI brokers?

This year, Top 100 UK brokers Jensten, Lloyd & Whyte and Clear have all joined amii, a trade body representing intermediaries advising on health insurance, protection and wellbeing services, while others have acquired in this space. Sam Barrett looks at why firms more closely associated with general insurance broking are branching out to capitalise on opportunities in the employee benefits market.

Most read articles loading...

You need to sign in to use this feature. If you don’t have an Insurance Age account, please register now.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an indvidual account here: